FRI is pleased to announce that Drs. Karen Alexander and Courtney Nordeck (MPIs) have received an R01 award from the National Institute on Nursing Research for their project, titled “A Patient Navigation Trial for Housing and Health (PATHH): A randomized controlled trial.” Co-investigators include Drs. Jan Gryczynski and Karli Hochstatter. This study is in collaboration with two Philadelphia-based community organizations – New Day and Women Against Abuse – who provide emergency housing and supportive services to women who have survived violence (WSV). WSV demonstrate high rates of housing instability and health problems, including increased morbidity and mortality related to substance use, depression, and HIV. Healthcare engagement for WSV is often limited by factors such as fragmented services, complex eligibility requirements, and inconsistent follow-up systems. Despite the established link between housing and health, there is a lack of evidence-based interventions designed to directly improve housing instability while simultaneously supporting improved connection to healthcare services. There is an urgent need for interventions that promote housing stability and improve continuity in care for WSV to reduce negative health outcomes. Building on the team’s prior patient navigation (PN) work and adapting the core components of the Navigation Services to Avoid Re-hospitalization (NavSTAR) intervention, the study aims to develop and test a novel PN intervention, titled PATHH (Patient Navigation Trial for Housing and Health), which will focus on improving housing stability and health self-efficacy for WSV. This study will establish a Community Advisory Board to incorporate the perspectives and experiences of women with lived experience to adapt a PN intervention and to support PATHH’s implementation across individual, organizational, and community levels (Aim 1). The study will also evaluate the effectiveness of PATHH as an augmentation to existing services in partnership with community organizations (Aims 2 and 3). To assess effectiveness, we will conduct a parallel, two-arm randomized controlled trial among 300 WSV, who will be randomized to receive PATHH (N=150) or usual care (N=150). Primary outcomes will include housing stability and health self-efficacy; secondary outcomes include substance use, mental health, and physical health. We will also evaluate implementation outcomes at the conclusion of the trial. This study is significant in testing a scalable PN approach designed to improve housing stability and health for WSV and innovative in extending PN beyond traditional healthcare settings into community-based partnerships, while also generating evidence to guide future implementation of PN models.